Shaofei Zhou
Papers
1
Total Citations
4
H-Index
1
About
Shaofei Zhou is a leading clinical researcher in surgical oncology, with a primary focus on gastric cancer treatment and perioperative care. His work centers on optimizing outcomes for patients undergoing radical gastrectomy, particularly those with advanced disease who require neoadjuvant chemotherapy (NACT). Zhou’s major contribution lies in investigating the role of probiotic supplementation in enhancing short-term clinical outcomes after laparoscopic or robotic gastrectomy. His most-cited paper, a multicenter randomized controlled trial protocol from 2025 (4 citations), outlines a rigorous study design to evaluate how perioperative probiotics can mitigate complications and improve recovery in this high-risk population. This work addresses a critical gap in supportive care for gastric cancer patients, bridging oncology and gastrointestinal microbiome research. Zhou’s research has direct implications for clinical practice, offering a potential low-cost intervention to reduce postoperative morbidity. His achievements include leading the GISSG2023-01 Study, a collaborative effort that underscores his ability to design and coordinate complex multicenter trials. For students and researchers, Zhou exemplifies how translational research can improve surgical outcomes, making his profile a valuable resource for those interested in gastrointestinal oncology, perioperative medicine, and evidence-based surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1